UM Ventures News
![Gliknik Gliknik](https://www.umventures.org/sites/default/files/styles/medium/public/gliknik_logo.png?itok=9zgokTf-)
Gliknik Expands Clinical Development Team with New Senior Director and Adds Board Members
Wednesday, February 19, 2014
![CoolCAD Keychain Computer-Lock CoolCAD Keychain Computer-Lock](https://www.umventures.org/sites/default/files/styles/medium/public/coolcad.png?itok=fq6ttUdl)
UMCP's CoolCAD Kickstarts Its Keychain Computer-Lock
Wednesday, February 19, 2014
![DBED Secretary Dominick Murray, UMB Dr. Eduardo Davila, and BioMaryland Center Executive Director Judith A. Britz, Ph.D. DBED Secretary Dominick Murray, UMB Dr. Eduardo Davila, and BioMaryland Center Executive Director Judith A. Britz, Ph.D.](https://www.umventures.org/sites/default/files/styles/medium/public/life-prize.jpg?itok=k3v34fu2)
University of MD, Baltimore and Hopkins Faculty Researchers Win 2014 BioMaryland Life Prizes
Wednesday, February 19, 2014
![Harpoon Medical Harpoon Medical](https://www.umventures.org/sites/default/files/styles/medium/public/harpoon.png?itok=64UeIs5J)
University Of Maryland, Baltimore Licenses Cardiac Valve Repair Technology To Harpoon Medical
Tuesday, February 18, 2014
![Neuralstem Inc. Neuralstem Inc.](https://www.umventures.org/sites/default/files/styles/medium/public/neuralstem_logo.jpg?itok=1SBEKbMy)
Mtech TAP Incubator Graduate Neuralstem Inc. Closes $20 Million Investment
Saturday, February 15, 2014
![Alba Therapeutics Corporation Alba Therapeutics Corporation](https://www.umventures.org/sites/default/files/styles/medium/public/alba.jpg?itok=gvS2K8hB)
Congratulations to Alba Therapeutics for Reporting Positive Phase IIb Trial Results
Tuesday, February 11, 2014
![Douglas Ross Douglas Ross](https://www.umventures.org/sites/default/files/styles/medium/public/ross.jpg?itok=thlAz0Bz)
Commercial Success: UMB Researcher-Developed BCRP Patent Portfolio Licensed Three Times in 2013
Wednesday, February 5, 2014
![Rexahn Pharmaceuticals Rexahn Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/rexahn_logo.jpg?itok=CPnm_QUd)
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors
Thursday, January 23, 2014